From Prospective Evaluation to Practice: Model-Informed Dose Optimization in Oncology.

Drugs · 2025 · PMC11946950 · PMID 39939511

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

moderately significantno p-value reported

A subgroup analysis showed that the probability of a beneficial effect was 92.2%, which the authors classified as moderately significant.

also in 2,174 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.